** Test Mode **

  0.00 (USD)

This Package provides access to the entire event

Registration Header
REGISTER Today

Challenges and best practices for global patient engagement

Date:10/26/2021

Time:1:00 PM EDT

Duration:60 minutes



Global clinical trial success hinges on culturally appropriate patient engagement. We will be covering best practices to recruit and retain study patients in global clinical trials as well as delve into the biggest challenges in this area today and how the COVID-19 pandemic has impacted patient engagement. Join our experts as they share their real-world experiences and successes with global and cultural adaptation for effective patient recruitment and retention. These experiences touch on methods to overcome geographical, financial and educational barriers. Learn how your language service provider can support culturally appropriate and medically accurate language services and partnerships between study operations.

If you're already registered for the "Challenges and best practices for global patient engagement" webcast, click below:

ALREADY REGISTERED?

Speaker

Stéphane Millet

Life sciences production director

Acolad

Stéphane is responsible for developing strategic processes that will drive operational excellence within the Acolad Group and for ensuring the optimization of workflows and localized content for a highly regulated industry. Prior to joining Acolad in 2010, Millet worked as a translator and localization project manager in diverse operational functions. He is also a graduate of the faculty of translation studies, linguistics and cultural studies of the Johannes Gutenberg University in Mainz/Germersheim, Germany.

David Himmelberger

CEO

Health Outcomes Group

David Himmelberger has a Masters Degree in Statistics from Purdue University. In 2010 he was recognized as the Distinguished Science Alumnus by Purdue University. After graduating from Purdue he moved to Stanford University where he was a biostatistician in the School of Medicine, Department of Family, Community and Preventive Medicine, now the Department of Health Policy Research. While at Stanford he worked on numerous projects at the Med School. At Stanford he had the vision about the importance of quality of life as a primary outcome that would be used to approve new medical treatments and to guide patients and physicians in making decisions to select the best treatment option. David left Stanford in 1987 to found Health Outcomes Group, a consultancy focused on measuring health outcomes, especially internationally. One area of expertise at Health Outcomes Group is the translation and linguistic validation of questionnaires for use in multinational clinical trials. David has travelled to more than 70 countries to train linguists to conduct interviews of patients. He was a part of the ISPOR Task Force that created the Guidelines for Translation of Questionnaires Used in Cross-Cultural Research.
Share on Facebook Share on Twitter Share on Linkedin Share through Email

Sponsors

Sponsor Image
Challenges and best practices for global patient engagement
Registration Is Closed

© 2025 Notified. All rights reserved.
Already Registered? Technical Requirements System Check Port Troubleshooting